On June 16, 2020, the U.S. Patent and Trademark Office (USPTO) released final rules (the “Rules”) implementing changes to how Patent Term Adjustment (PTA) is calculated in certain circumstances in view of Supernus Pharms.,...more
6/24/2020
/ European Patent Office ,
Final Rules ,
Information Disclosure Statement ,
Patent Applications ,
Patent Litigation ,
Patent Prosecution ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patents ,
Request for Continued Examination ,
USPTO
The United States Patent and Trademark Office (USPTO) has recently launched two new initiatives to support COVID-19 innovations: 1) a COVID-19 Prioritized Examination Pilot Program, and 2) Patents 4 Partnerships that provides...more
5/15/2020
/ Artificial Intelligence ,
Coronavirus/COVID-19 ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Patent Applications ,
Patent Examinations ,
Patents ,
Prioritized Examination ,
Request for Continued Examination ,
USPTO ,
USPTO Pilot Program